Acupuncture Versus Clomiphene for Ovulation Induction in Women With Polycystic Ovary Syndrome (PCOS): A Randomized Clinical Trial

Hafizi L, Azizi H, Mahmoudinia M, Jafari M, Taghanaki HB, Esmaili H, Golmohammadzadeh S, Azizi H

Published June 2026 Health science reports, 9(6), e72673
DOI 10.1002/hsr2.72673 PMID 42327481 PMC PMC13282259

RRM Academy Synopsis

Acupuncture and clomiphene showed no significant ovulation gap in PCOS

A randomized trial of 77 women with PCOS in Iran found no significant gap in ovulation between acupuncture and clomiphene. Clomiphene brought larger follicles by the third cycle. Acupuncture brought more headaches.

Key Findings

  • Across all cycles, 27 of 74 women (36.5%) ovulated. The two groups did not differ significantly (p = 0.36).
  • In the third cycle, 31 of 39 women (79.5%) in the clomiphene group had a follicle larger than 18 mm, against 3 of 38 in the acupuncture group (p = 0.001).
  • Headache was reported by 13 of 38 women (34.2%) in the acupuncture group and 2 of 39 in the clomiphene group (p = 0.001).
  • Of 82 women initially included, 77 were analyzed (38 acupuncture, 39 clomiphene). Ovulation could not be assessed in two women in the acupuncture group and one in the clomiphene group.

Interpretation

The study was a single-blind, sham-controlled randomized trial. Every woman received one real and one dummy treatment: acupuncture with placebo tablets, or clomiphene with sham needling. Participants were infertile women aged 20 to 40 with PCOS at two Mashhad centers, treated for up to three cycles. The main result measured was ovulation confirmed by ultrasound. The authors note that clomiphene was increased across cycles while acupuncture sessions were not.

RRM Context

Restorative reproductive medicine looks for the cause of missed ovulation in each woman with PCOS. PCOS is also called PMOS, Polyendocrine Metabolic Ovarian Syndrome. Cycle charting shows a woman and her clinician whether ovulation is returning. The trial compared two ways of prompting ovulation, one drug-based and one needle-based, over up to three cycles.

Abstract

Background and Aims

There is evidence of the beneficial effects of acupuncture in the treatment of polycystic ovary syndrome (PCOS). This study aimed to compare acupuncture with clomiphene in ovulation induction among infertile women with PCOS.

Methods

This randomized clinical trial was conducted on infertile women with PCOS who were referred to the gynecology clinic of Imam Reza Hospital and Milad Infertility Center, Mashhad, Iran, from December 2015 to July 2016. Patients were randomly assigned to two groups; the intervention group (38 patients) received true acupuncture plus placebo clomiphene, whereas the control group (39 patients) received clomiphene plus sham acupuncture. Patients were compared in terms of folliculare growth, evidence of ovulation, and side effects of treatment.

Results

There was no statistically significant difference between the two groups in terms of demographic characteristics and PCOS criteria. The ovulation rates were 31.5% and 41.6% in the intervention and control groups respectively, indicating no statistically significant difference(p = 0.36). Also, in terms of side effects, the statistical difference between the two groups was not significant, except for headache which was significantly more common in the intervention group (p = 0.001). The rate of folliculargrowth was significantly higher in the control group during the first and third cycles (p = 0.01), whereas no significant difference was observed in the second cycle (p = 0.93).

Conclusion

Acupuncture can be as effective as clomiphene treatment in inducing ovulation in infertile women with PCOS. Moreover, considering the few side effects of acupuncture, its application can be considered a safe option.

Trial Registration

IRCT201512057265N3.

Related research

Leili Hafizi, Hamideh Azizi, Malihe Mahmoudinia, Mona Jafari, Hamidreza Bahrami Taghanaki, Habibollah Esmaili, Shiva Golmohammadzadeh, Hoda Azizi
L Hafizi, H Azizi, M Mahmoudinia, M Jafari, H Taghanaki, H Esmaili, S Golmohammadzadeh
PMID 42327481 42327481 DOI 10.1002/hsr2.72673 10.1002/hsr2.72673 Hafizi et al. 2026, Hafizi 2026